<DOC>
	<DOCNO>NCT01205334</DOCNO>
	<brief_summary>Patients type brain cancer call glioblastoma multiforme . Because GBMs come back standard therapy , patient ask volunteer take part research study use special immune cell . They may already think study . Some patient GBM show evidence infection virus call Cytomegalovirus time diagnosis . CMV find cancer cell patient GBM , suggest may play role cause disease . The cancer cell infect CMV able hide body 's immune system escape destruction . We want see special white blood cell , call T cell , train recognize kill special part CMV infect cell survive blood affect tumor . We use sort therapy treat different type cancer positive virus variable result . Some patient responses others . It possible u predict treatment work GBM . The purpose study find large safe dose CMV-T cell , learn side effect , see whether therapy might help patient GBM .</brief_summary>
	<brief_title>Administration CMV-Specific Cytotoxic T Cells Patients With Glioblastoma Multiforme</brief_title>
	<detailed_description>To generate CMV-T cell put specially produce carrier virus ( adenovirus ) carry one CMV gene patient 's blood monocyte dendritic cell . These cell use train patient 's T cell kill cell CMV surface . We grow CMV-T cell stimulation Epstein-Barr virus ( EBV ) infect cell patient 's blood , also contain adenovirus CMV gene . When patient enrolls study , assign dose CMV-T cell . The patient give injection cell vein IV line assign dose . The patient follow clinic injection 1 4 hour . If 6 week evaluation period infusion , patient seem experience benefit ( tumor regression confirm radiological study , physical exam and/or symptom ) , may able receive six additional dos T cell wish . These additional infusion would least 1 3 month apart dose level receive first time . Medical test treatment -- Before treat , patient receive series standard medical test : Physical exam , Pregnancy test ( applicable ) , Blood test measure blood cell , kidney liver function , Measurements tumor routine image study Medical test treatment -- The patient receive standard medical test get infusion : Physical exam , Blood test measure blood cell , kidney liver function , Measurements tumor routine image study 6 week infusion To learn way CMV-T cell work long last body , blood take day T-cell infusion , end T-cell infusion , 1 , 2 , 4 6 week T-cell infusion every 3 month 1 year . Total time participation study 1 year .</detailed_description>
	<mesh_term>Glioblastoma</mesh_term>
	<mesh_term>Brain Neoplasms</mesh_term>
	<criteria>INCLUSION CRITERIA : Histopathological verification glioblastoma multiforme ( GBM : WHO grade IV ) remission ( Group A ) active disease ( Group B ) . CMVpositive GBM CMV seropositive Life expectancy 6 week great Karnofsky/Lansky score 50 great Patient parent/guardian capable providing inform consent Bilirubin le 1.5x upper limit normal , AST le 3x upper limit normal , serum creatinine le 1.5x normal Hgb 8.0 g/dL great Pulse oximetry 90 % great room air Sexually active patient must willing utilize one effective birth control method 6 month CTL infusion . The male partner use condom . Patients investigational antineoplastic therapy one month prior entry study . Informed consent explain , understood sign patient/guardian . Patient/guardian give copy inform consent . EXCLUSION CRITERIA : Severe intercurrent infection Known HIV positivity Pregnant lactate History hypersensitivity reaction murine proteincontaining product .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>Glioblastoma multiforme</keyword>
	<keyword>GBM</keyword>
	<keyword>Brain Cancer</keyword>
	<keyword>CTL</keyword>
</DOC>